[1]
Yohei Noguchi et al. 2019. Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy? . Turkish Journal of Gastroenterology. 27, 2 (Jul. 2019), 165–172.